Normofludil Forte (Acetylcysteine)

Acetylcysteine is used as a mucolytic to improve airway clearance in several respiratory conditions.

• Chronic bronchitis: reduces sputum thickness and aids expectoration.
• Chronic obstructive pulmonary disease (COPD): facilitates mucus clearance and may improve breathing comfort.
• Acute bronchitis: helps relieve productive cough by thinning secretions.
• Cystic fibrosis: assists in clearing thick pulmonary mucus, supporting airway hygiene.

• Acetylcysteine acts by cleaving disulfide bonds within mucus glycoproteins, which lowers the polymeric network’s viscosity. The reduced mucus thickness enhances ciliary transport and cough effectiveness, promoting clearance from the airways. Additionally, the sulfhydryl group serves as a precursor for intracellular glutathione, helping to replenish antioxidant defenses in respiratory epithelium. By restoring redox balance, acetylcysteine may also reduce inflammation associated with oxidative stress.

Acetylcysteine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild stomach upset often reported.
• Vomiting: occasional emesis after oral intake.
• Diarrhea: loose stools in some patients.
• Abdominal discomfort: cramping or pain.
• Rash: skin redness or itching.
• Metallic taste: transient taste alteration.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Severe bronchospasm: sudden airway narrowing, especially in asthmatic patients.
• Angioedema: swelling of face, lips, or throat.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Hypotension: significant drop in blood pressure.

When prescribing acetylcysteine, consider the following precautions to ensure safe use.

• Renal function: assess kidney status in patients with chronic renal disease.
• Hepatic impairment: use with caution and monitor liver enzymes.
• Asthma: monitor for bronchospasm, especially after inhaled administration.
• Peptic ulcer disease: avoid if active ulceration is present due to potential irritation.
• Hypersensitivity: discontinue if signs of allergic reaction appear.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Acetylcysteine can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Nitroprusside: concurrent use may cause profound hypotension.
• Activated charcoal: reduces oral absorption of acetylcysteine.
• Chemotherapeutic agents requiring glutathione (e.g., cyclophosphamide): may diminish efficacy.

Moderate Interactions (Monitor Closely)

• Anticoagulants (warfarin, DOACs): potential increase in bleeding risk.
• Antihistamines: may enhance sedative effects.
• Certain antibiotics (carbapenems): possible reduction in mucolytic activity.
• Bronchodilators: monitor for additive bronchospasm risk.